Louisiana 2026 Regular Session Status: Enacted Bipartisan · 52 R · 27 D cosponsors

SB 43 — HEALTH SERVICES: Provides relative to psychedelic-assisted therapy. (8/1/26) (EN INCREASE GF EX See Note)

Last action — Becomes Act No. 956 without the Governor's signature.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed Senate
  4. ✓
    Passed House
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced February 12, 2026. Enacted.

Signed by Governor Jeff Landry (Republican) on June 21, 2026.

Odds of enactment

High chance

Based on the sponsor, cosponsors, and committee posture, this bill has a high chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Likely to advance 98% · high confidence

  • Enacted

    Current position in the legislative process.

  • 83 sponsors

    1 primary, 82 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (52 R · 27 D) — cross-party backing.

  • Cleared a recorded vote

    Passed 6 recorded votes so far.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

In plain language

The bill establishes guidelines for psychedelic-assisted therapy in health services.

This legislation provides a framework for the use of psychedelic substances in therapy. It aims to regulate their application and ensure safety in treatment settings.

Bill Text

What changed in the latest version

154 added · 189 removed

Plain-language change summary

In the updated version of Bill SB 43, a reference to "ACT No. 956" has been removed. This change likely simplifies the bill by eliminating a specific mention that may no longer be relevant or necessary. Removing this reference could help clarify the bill's intent and make it easier for everyone to understand the proposed legislation.

→
Previous
Latest
SLS 26RS-83 REENGROSSED Regular Session SENATE BILL NO.
Regular Session ENROLLED SENATE BILL NO.
43 BY SENATORS MCMATH, BARTHELEMY, BASS, BOUDREAUX, CARTER, CLOUD, CONNICK, DUPLESSIS, EDMONDS, FESI, HARRIS, HENRY, HENSGENS, JACKSON-ANDREWS, JENKINS, KLEINPETER, LUNEAU, MIGUEZ, MILLER, MIZELL, MYERS, OWEN,PRICE,SEABAUGH,SELDERS, STINE,TALBOT,WHEAT AND WOMACK HEALTH SERVICES.
43 BY SENATORS MCMATH, BARTHELEMY, BASS, BOUDREAUX, CARTER, CLOUD, CONNICK, DUPLESSIS, EDMONDS, FESI, HARRIS, HENRY, HENSGENS, JACKSON-ANDREWS, JENKINS, KLEINPETER, LUNEAU, MIGUEZ, MILLER, MIZELL, MYERS, OWEN,PRICE,SEABAUGH,SELDERS, STINE,TALBOT,WHEAT AND WOMACK AND REPRESENTATIVES ADAMS, BAYHAM, BERAULT, BILLINGS, BOYD, BOYER, BRASS, BROUSSARD, BRYANT, CARPENTER, CARVER, CHASSION, CHENEVERT, COATES, COX, CREWS, DESHOTEL, DEWITT, DICKERSON, DOMANGUE, ECHOLS, EGAN, FISHER, FREEMAN, FREIBERG, GLORIOSO, HEBERT, CHANCE HENRY, HILFERTY, HORTON, JACKSON,MIKEJOHNSON,KERNER,KNOX,LAFLEUR, JACOB LANDRY, LYONS, MACK, MCMAKIN, MELERINE, MILLER, MOORE, MURRAY, RISER, SAWYER, SCHAMERHORN, SPELL, ST.
Provides relative to psychedelic-assisted therapy.
BLANC, STAGNI, TAYLOR, VENTRELLA, WALTERS, WRIGHT AND WYBLE AN ACT To enact Part IX of Chapter 1 of Title 28 of the Louisiana Revised Statutes of 1950, to be comprised of R.S.
(8/1/26) AN ACT To enact Part IX of Chapter 1 of Title 28 of the Louisiana Revised Statutes of 1950, to be comprised of R.S.
to provide for clinical trial- enabling studies;
to provide for patient eligibility;
to provide for patienteligibility;toprovideforfunding;toprovideforreporting;andtoprovidefor related matters.
to provide for funding;
to provide for reporting;
and to provide for related matters.
28:211 and 212, are herebyenacted to read as follows:
28:211 and 212, is hereby enacted to read as follows:
(1)"Academichealth center" means an organization that has amedical school, one or more other health professional schools or programs, and one or more affiliated teaching hospitals.
(1) "Academic health center"means an organization thathas a medical school, one or more other health professional schools or programs, and one or more affiliated teaching hospitals.
(2)"Drugdeveloper"means apharmaceuticalcompany, biotechnology Page 1 of 7 Coding:
(2)"Drugdeveloper"means apharmaceuticalcompany, biotechnology company,orcontractdevelopmentandmanufacturingorganizationengagedin drug development and manufacturing.
Page 1 of 6 Coding:
SLS 26RS-83 REENGROSSED SB NO.
SB NO.
43 company,orcontractdevelopmentandmanufacturingorganizationengagedin drug development and manufacturing.
43 ENROLLED (3) "Ibogaine" means ibogaine and ibogaine-based therapeutics, including ibogaine analogs.
(3) "Ibogaine" means ibogaine and ibogaine-based therapeutics, including ibogaine analogs.
(4) "Psychedelic medication" means ibogaine, ibogaine-based therapeutics, ibogaine analogs, MDMA, psilocybin, psilocybin-based therapeutics, and mechanistically-similar analogs.
(4) "Psychedelic medication" means ibogaine, ibogaine-based therapeutics, ibogaine analogs, psilocybin, psilocybin-based therapeutics, and mechanistically-similar analogs.
(5) "Psychedelic-assisted therapy" means an intervention that includes the administration of a psychedelic medication to an individual in a controlled clinical settingand manualized, trauma-informed preparatoryand integrative psychotherapy delivered by a qualified therapist to the individual before and after administration of the psychedelic medication.
(5) "Psychedelic-assisted therapy" means an intervention that includes the administration of a psychedelic medication to an individual in a controlled clinical setting and manualized, trauma-informed preparatoryand integrative psychotherapy delivered by a qualified therapist to the individual before and after administration of the psychedelic medication.
The purpose of the initiative shall be:
The purpose of the initiative shall be all of the following:
(4) To designate a state point of contact to coordinate with federal agencies and other states with regard to psychedelic-assisted therapy and related drug development.
Each participating academic health center shall maintain documentation ensuring compliance with state and federal regulations, Page 2 of 7 Coding:
Each participating academic health center shall maintain documentation ensuring compliance with state and federal regulations, Page 2 of 6 Coding:
SLS 26RS-83 REENGROSSED SB NO.
SB NO.
43 including:
43 ENROLLED including all of the following:
(1) Ensuring that the clinical study will be conducted under an FDA investigational new drug application, expanded access program, or other federally authorized pathway.
(1)Ensuringthattheclinicalstudywillbeconductedinaccordancewith a United States Food and Drug Administration investigational new drug application, expanded access program, or other federally authorized pathway.
(2)Ensuringthatanystudywillbeconductedon-siteinahospital,clinic, or research unit affiliated with the academic center, with confirmation of appropriate liability insurance coverage.
(2)Ensuringthatanystudywillbeconductedon-siteinahospital,clinic, or research unit affiliated with the academic center, with confirmation of appropriate trial liability insurance coverage.
(5) A clinical study protocol that includes:
(5) A clinical study protocol that includes all of the following:
(6) A drug administration plan for the clinical study that includes:
(6) A drug administration plan for the clinical study that includes all of the following:
(7)Asafetymonitoring and risk management plan fortheclinicalstudy that includes:
(7)Asafetymonitoring and risk managementplan fortheclinicalstudy that includes all of the following:
Page 3 of 7 Coding:
Page 3 of 6 Coding:
SLS 26RS-83 REENGROSSED SB NO.
SB NO.
43 (b) On-site emergency response procedures.
43 ENROLLED (b) On-site emergency response procedures.
(8) A fidelity plan for the clinical study that includes:
(8)Afidelityplanfortheclinicalstudythatincludesallofthefollowing:
Eligible participants include individuals with opioid use disorders, co-occurring substance usedisorders,andtreatment-resistantneurological ormentalhealth conditions.
Eligible participants include individuals with opioid use disorders, co-occurring substance use disorders,and treatment-resistantneurologicalormentalhealth conditions.
G.
(3) To the extent feasible, the Louisiana Department of Health shall support and encourage the use of opioid settlement funds and other related monies as matching funds for federal or other external funding opportunities in support of Louisiana trial and trial-enabling studies.
NolaterthanJanuaryfirstofeachyear,eachacademichealth center participating in the program shall submit a progress report to the department onclinicalstudiesconductedbythecenter.Thedepartmentshalldeterminethe data required for inclusion in the report.
G.NolaterthanJanuaryfirstof eachyear,eachacademichealthcenter participating in the program shall submit a progress report to the Louisiana Department of Health on clinical studies conducted by the academic health center.The Louisiana Department of Health shall determine thedata required for inclusion in the report.
The department shall prepare a compiledreportofthedatareceivedfromparticipatingacademichealthcenters and submit the report to the legislature by March first of each year.
The Louisiana Department of Health shall prepare Page 4 of 6 Coding:
H.
To the extent feasible, participating academic health centers shall coordinate with other states that are conducting clinical trials for use of Page 4 of 7 Coding:
SLS 26RS-83 REENGROSSED SB NO.
SB NO.
43 psychedelic-assisted therapy.
43 ENROLLED a compiled report of the data received from participating academic health centers and submit the report to the legislature by March first of each year.
Show all 96 changed rows (56 more)
Previous
Latest
H.
To the extent feasible, participating academic health centers shall coordinate with other states that are conducting clinical trials for use of psychedelic-assisted therapy.
Drug development of ibogaine treatment A.
Drug development of ibogaine and psychedelic medication treatments A.
An academic health center may enter into an agreement with a drug developer to establish a consortium for purpose of conducting drug development clinical trials with ibogaine and securing the United States Food and Drug Administration's approval of ibogaine as a medication for the treatmentof opioid use disorder,co-occurringsubstance use disorder,and any otherneurological ormentalhealthcondition forwhichibogainedemonstrates efficacy.
An academic health center may enter into an agreement with a drug developer to establish a consortium for the purpose of conducting drug developmentclinicaltrialswithibogaineandpsychedelicmedicationtreatments and securing the United States Food and Drug Administration's approval of such treatments for the treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health condition for which the treatments demonstrate efficacy.
A consortium seeking to conduct an ibogaine drug development clinical trial shall:
A consortium seeking to conduct a drug development clinical trial may do all of the following:
(1) Submit an investigational new drug application to the FDA in accordance with 21 CFR Part 312.
(1) Submit an investigational new drug application to the United States Food and Drug Administration in accordance with 21 CFR Part 312.
(2)SeekabreakthroughtherapydesignationforibogainefromtheFDA under 21 U.S.C.
(2) Seek a breakthrough therapy designation from the United States Food and Drug Administration in accordance with 21 U.S.C.
(a)HassubmittedaninvestigationalnewdrugapplicationtotheFDAin accordance with 21 CFR Part 312.
(a)Has submittedan investigational new drug application totheUnited States Food and Drug Administration in accordance with 21 CFR Part 312.
(b)Hasrequestedabreakthroughtherapydesignationforibogainefrom the FDA under 21 U.S.C.
(b)Hasrequestedabreakthroughtherapydesignationforibogainefrom the United States Food and Drug Administration in accordancewith 21 U.S.C.
(4) Work with the FDA to coordinate the drug development trial in Louisiana with ibogaine drug development trials that are being conducted in other states.
(4) Work with the United States Food and Drug Administration to coordinate the drug development trial in Louisiana with drug development trials that are being conducted in other states.
C.(1) Any revenue attributable to all intellectual property rights and other commercial rights arising from drug development clinical trials conductedbyaconsortiumpursuanttothisSection,duringtheperiodforwhich the trials are funded, and any following period of commercialization shall be Page 5 of 7 Coding:
Page 5 of 6 Coding:
SLS 26RS-83 REENGROSSED SB NO.
SB NO.
43 allocated as follows:
43 ENROLLED C.(1)Anyrevenueattributabletonewlydevelopedintellectualproperty andothercommercialrightsarisingfromtrial-enablinganddrugdevelopment clinicaltrialactivityconductedbyaconsortiumpursuanttothisSection,during the period for which the trials are funded, and any following period of commercialization shall be allocated as follows:
(a) Not less than twenty percent to the state.
(a) Not less than a two and one-half percentof net sales running royalty to the state.
(2)Intellectualpropertyrightsandothercommercialrightsarisingfrom the drug development clinical trials conducted pursuant to this Section shall include any of the following as related to the trials:
(2) Intellectual property and other commercial rights arising from the drugdevelopmentclinicaltrialsconductedpursuanttothisSectionshallinclude any of the following as related to the trials:
The original instrument and the following digest, which constitutes no part of the legislative instrument, were prepared bySenate Legislative Services.
PRESIDENT OF THE SENATE SPEAKER OF THE HOUSE OF REPRESENTATIVES GOVERNOR OF THE STATE OF LOUISIANA APPROVED:
The keyword, summary, and digest do not constitute part of the law or proof or indicia of legislative intent.
Page 6 of 6 Coding:
[R.S.
1:13(B) and 24:177(E)] DIGEST SB 43 Reengrossed 2026 Regular Session McMath Proposed law establishes the Psychedelic-Assisted Therapy Initiative within the La.
Dept.
of Health, office of behavioral health.
Proposed law establishes the following purposes of the initiative:
(1) To identifyacademic health centers that are conducting clinical studies and clinical trial-enablingstudies for the use of psychedelic-assistedtherapyforthetreatmentof opioid use disorders, co-occurring substance use disorders, and treatment-resistant neurological or mental health conditions.
(2) Toutilizethehumanservicedistrictsandauthoritiestoidentifyeligibleparticipants.
(3) To provide information to allow parishes utilizing opioid settlement funds to enroll eligible patients residing in the parish to participate in the studies or to support clinical trial-enabling studies.
Proposed law authorizes the department to seek and receivefederalfunds, gifts, grants, and donations for the program in addition to utilizing opioid settlement funds.
Page 6 of 7 Coding:
Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions.
SLS 26RS-83 REENGROSSED SB NO.
43 Proposed law requires participating academic health centers to submit an annual progress report to the department and requires the department to submit a compiled report to the legislature by March 1st of each year.
Proposed law requires the participating academic health centers to coordinate with other states that are conducting clinical trials for use of psychedelic-assisted therapyto the extent feasible.
Proposed law authorizes academic health centers to enter into agreements with drug developers to establish a consortium for purposes of conducting drug development clinical trials with ibogaine and provides for the process to establish a consortium.
Proposedlawprovidesforthedistributionofanyrevenueattributabletointellectualproperty rights and other commercial rights arising from drug development clinical trial.
Effective August 1, 2026.
(Adds R.S.
28:211 and 212) Summary of Amendments Adopted by Senate Committee Amendments Proposed bySenate Committee on Health and Welfare to the original bill 1.
Changes requirementsrelativeto theLa.Dept.ofHealth's rolein overseeing the clinical trials.
2.
Changesrequirementsrelativetorequireddocumentationforacademichealth centers conducting trials.
3.
Authorizes academic health centers to enter into agreements with drug developersto conductibogaineclinicaltrialsandparticipateinaconsortium with other states.
Senate Floor Amendments to engrossed bill 1.
Changes the Psychedelic-Assisted Therapy Program to an initiative within the La.
Dept.
of Health.
2.
Moves certain program requirements from the La.
Dept.
of Health to the human service districts and authorities and the academic health centers.
3.
Changescertainclinicalstudyrequirementsforparticipatingacademichealth centers.
4.
Changes the submission date of the La Dept.
of Health's report to the legislature.
Page 7 of 7 Coding:
⬇ Download PDF
View plain text versions (6)

Amendments

6 amendments

Click Show changes on an amendment above to see how it modifies the bill.

Action History

  1. Becomes Act No. 956 without the Governor's signature.

  2. Effective date 8/1/2026.

  3. Enrolled. Signed by the President of the Senate.

  4. Signed by the Speaker of the House.

  5. Sent to the Governor by the Secretary of the Senate.

  6. Conference Committee Report read, roll called, yeas 97, nays 0. The Conference Committee Report was adopted.

  7. Notice House adopted the Conference Committee Report.

  8. Conference Committee Report read; adopted by a vote of 35 yeas and 0 nays.

  9. Notice of Senate adoption of Conference Committee Report.

  10. Scheduled for floor debate on 05/31/2026.

  11. Scheduled for floor debate on 05/29/2026.

  12. Conference Committee report received. Lies over under the rules.

  13. Conference committee report received.

  14. Notice of Senate conferees appointed.

  15. Senate conference committee members appointed: McMath, Luneau, and Owen.

  16. House conferees appointed: Riser, Miller, and Egan.

  17. Notice House Conference Committee members appointed.

  18. Amendments proposed by the House read and rejected by a vote of 34 yeas and 1 nays.

  19. Notice of Senate rejecting House amendments.

  20. Received from the House with amendments.

  21. Read third time by title, amended, roll called on final passage, yeas 97, nays 0. Finally passed, ordered to the Senate.

  22. Scheduled for floor debate on 05/07/2026.

  23. Read by title, amended, passed to 3rd reading.

  24. Reported without Legislative Bureau amendments.

  25. Reported with amendments (9-0). Referred to the Legislative Bureau.

  26. Read by title, under the rules, referred to the Committee on Health and Welfare.

  27. Received in the House from the Senate, read by title, lies over under the rules.

  28. Called from the Calendar.

  29. Senate floor amendments read and adopted. Read by title and passed by a vote of 37 yeas and 0 nays; ordered reengrossed and sent to the House. Motion to reconsider tabled.

  30. Read by title and returned to the Calendar, subject to call.

  31. Rules suspended. Recalled from Committee.

  32. Read by title and passed to third reading and final passage.

  33. Read by title. Committee amendments read and adopted; ordered engrossed and recommitted to the Committee on Finance.

  34. Reported with amendments.

  35. Introduced in the Senate; read by title. Rules suspended. Read second time and referred to the Committee on Health and Welfare.

  36. Prefiled and under the rules provisionally referred to the Committee on Health and Welfare.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 82 co-sponsors · 64 not signed on

Sponsors (1)

Co-sponsors (82)

Not signed on (64)

64 members have not signed on to this bill.

Show all 64 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

ADOPT CONFERENCE REPORT (#1793)

Passed 97 Yea · 0 Nay · 8 Other
Party YeaNayPresentNot Voting
Democrat 27003
Republican 65003
Unaffiliated 5002
Total 97008
% of votes cast 92%0%0%8%
How each member voted (105)
Member Party Vote
Amedee — Yea
Stagni — Yea
Mr. Speaker — Not Voting
Galle — Not Voting
Johnson, T. — Yea
Landry, T. — Yea
St. Blanc — Yea
Adrian Fisher Democrat Yea
Aimee Adatto Freeman Democrat Yea
Alonzo L. Knox Democrat Yea
Barbara Carpenter Democrat Yea
C. Denise Marcelle Democrat Yea
Candace N. Newell Democrat Yea
Chasity Martinez Democrat Yea
Dana Henry Democrat Yea
Delisha Boyd Democrat Yea
Ed Murray Democrat Yea
Edmond Jordan Democrat Yea
Gerald Boudreaux Democrat Yea
III, Ed Larvadain Democrat Yea
Joy Walters Democrat Not Voting
Jr., Kyle M. Green Democrat Yea
Ken Brass Democrat Yea
Mandie Landry Democrat Yea
Marcus Anthony Bryant Democrat Yea
Pat Moore Democrat Yea
Rashid Armand Young Democrat Not Voting
Robby Carter Democrat Yea
Rodney Lyons Democrat Yea
Roy Daryl Adams Democrat Yea
Shaun Raphael Mena Democrat Yea
Sr., Wilford Carter Democrat Not Voting
Steven Jackson Democrat Yea
Sylvia Elaine Taylor Democrat Yea
Tammy T. Phelps Democrat Yea
Tehmi Jahi Chassion Democrat Yea
Vanessa Caston LaFleur Democrat Yea
Annie Spell Republican Yea
Barbara Reich Freiberg Republican Yea
Beth Anne Billings Republican Yea
Brett F. Geymann Republican Not Voting
Brian Leonard Glorioso Republican Yea
Bryan Fontenot Republican Yea
Chad Michael Boyer Republican Yea
Chance Keith Henry Republican Yea
Christopher Turner Republican Yea
Danny McCormick Republican Yea
Daryl Andrew Deshotel Republican Yea
Debbie Villio Republican Yea
Dixon Wallace McMakin Republican Yea
Dodie Horton Republican Yea
Emily Chenevert Republican Yea
Foy Bryan Gadberry Republican Yea
Francis C. Thompson Republican Yea
Gregory A. Miller Republican Yea
III, Roger William Wilder Republican Yea
III, Vincent E. Cox Republican Yea
IV, Gerald "Beau" Beaullieu Republican Yea
Jack McFarland Republican Yea
Jacob Braud Republican Yea
Jacob Jules Landry Republican Yea
Jason Brian DeWitt Republican Yea
Jeffrey "Jeff" Fons Wiley Republican Yea
Jeremy LaCombe Republican Yea
Jerome Zeringue Republican Yea
Jessica Domangue Republican Yea
John E. Wyble Republican Yea
Joseph A. Orgeron Republican Yea
Josh Carlson Republican Yea
Jr., Dennis Bamburg Republican Yea
Jr., John R. Illg Republican Yea
Jr., Michael Robert Bayham Republican Not Voting
Kathy Edmonston Republican Yea
Kellee Hennessy Dickerson Republican Yea
Kim Carver Republican Yea
Kimberly Landry Coates Republican Yea
Larry A. Bagley Republican Not Voting
Lauren Ventrella Republican Yea
Laurie Schlegel Republican Yea
Les Farnum Republican Yea
Mark Wright Republican Yea
Michael "Gabe" Firment Republican Yea
Michael Charles Echols Republican Yea
Michael Melerine Republican Yea
Mike Johnson Republican Yea
Neil Riser Republican Yea
Nicholas Muscarello Republican Yea
Paul Sawyer Republican Yea
Phillip Eric Tarver Republican Yea
Polly Thomas Republican Yea
R. Dewith Carrier Republican Yea
Raymond J. Crews Republican Yea
Reese "Skip" Broussard Republican Yea
Rhonda Gaye Butler Republican Yea
Robert "Bob" Owen Republican Yea
Rodney Schamerhorn Republican Yea
Ryan Bourriaque Republican Yea
Shane Mack Republican Yea
Sr., Peter F. Egan Republican Yea
Stephanie H. Berault Republican Yea
Stephanie Hilferty Republican Yea
Timothy P. Kerner Republican Yea
Tony Bacala Republican Yea
Troy Jude Hebert Republican Yea
Wayne McMahen Republican Yea

Official roll call →

ADOPT (#1565)

Passed 35 Yea · 0 Nay · 4 Other
Party YeaNayPresentNot Voting
Unaffiliated 1000
Republican 25002
Democrat 9002
Total 35004
% of votes cast 90%0%0%10%
How each member voted (39)
Member Party Vote
Mr. President — Yea
Edward J. Price Democrat Yea
Gary Carter Democrat Yea
Gerald Boudreaux Democrat Yea
Jay Luneau Democrat Not Voting
Jimmy Harris Democrat Yea
Katrina R. Jackson-Andrews Democrat Yea
Larry Selders Democrat Not Voting
Regina Barrow Democrat Yea
Royce Duplessis Democrat Yea
Sam Jenkins Democrat Yea
Sidney Barthelemy II Democrat Yea
Adam Bass Republican Yea
Alan Seabaugh Republican Yea
Beth Mizell Republican Yea
Blake Miguez Republican Yea
Bob Hensgens Republican Yea
Brach Jerad Myers Republican Yea
Caleb Kleinpeter Republican Yea
Eddie J. Lambert Republican Yea
Franklin J. Foil Republican Not Voting
Glen Womack Republican Not Voting
Gregory A. Miller Republican Yea
Heather Cloud Republican Yea
Jeremy Stine Republican Yea
John C. "Jay" Morris Republican Yea
Jr., William "Bill" Wheat Republican Yea
Kirk Talbot Republican Yea
Mark Abraham Republican Yea
Michael "Big Mike" Fesi Republican Yea
Mike Reese Republican Yea
Patrick Connick Republican Yea
Patrick McMath Republican Yea
Rick Edmonds Republican Yea
Robert "Bob" Owen Republican Yea
Robert Allain Republican Yea
Stewart Jr. Cathey Republican Yea
Thomas A. Pressly Republican Yea
Valarie Hodges Republican Yea

Official roll call →

REJECT (#892)

Passed 34 Yea · 1 Nay · 4 Other
Party YeaNayPresentNot Voting
Unaffiliated 1000
Republican 24003
Democrat 9101
Total 34104
% of votes cast 87%3%0%10%
How each member voted (39)
Member Party Vote
Mr. President — Yea
Edward J. Price Democrat Yea
Gary Carter Democrat Yea
Gerald Boudreaux Democrat Yea
Jay Luneau Democrat Yea
Jimmy Harris Democrat Yea
Katrina R. Jackson-Andrews Democrat Nay
Larry Selders Democrat Not Voting
Regina Barrow Democrat Yea
Royce Duplessis Democrat Yea
Sam Jenkins Democrat Yea
Sidney Barthelemy II Democrat Yea
Adam Bass Republican Yea
Alan Seabaugh Republican Yea
Beth Mizell Republican Yea
Blake Miguez Republican Yea
Bob Hensgens Republican Yea
Brach Jerad Myers Republican Yea
Caleb Kleinpeter Republican Yea
Eddie J. Lambert Republican Not Voting
Franklin J. Foil Republican Yea
Glen Womack Republican Not Voting
Gregory A. Miller Republican Yea
Heather Cloud Republican Yea
Jeremy Stine Republican Yea
John C. "Jay" Morris Republican Yea
Jr., William "Bill" Wheat Republican Yea
Kirk Talbot Republican Yea
Mark Abraham Republican Yea
Michael "Big Mike" Fesi Republican Yea
Mike Reese Republican Yea
Patrick Connick Republican Not Voting
Patrick McMath Republican Yea
Rick Edmonds Republican Yea
Robert "Bob" Owen Republican Yea
Robert Allain Republican Yea
Stewart Jr. Cathey Republican Yea
Thomas A. Pressly Republican Yea
Valarie Hodges Republican Yea

Official roll call →

FINAL PASSAGE (#997)

Passed 97 Yea · 0 Nay · 8 Other
Party YeaNayPresentNot Voting
Unaffiliated 6001
Republican 64004
Democrat 27003
Total 97008
% of votes cast 92%0%0%8%
How each member voted (105)
Member Party Vote
Mr. Speaker — Yea
Amedee — Yea
Galle — Yea
Stagni — Yea
Johnson, T. — Yea
Landry, T. — Not Voting
St. Blanc — Yea
Adrian Fisher Democrat Yea
Aimee Adatto Freeman Democrat Yea
Alonzo L. Knox Democrat Yea
Barbara Carpenter Democrat Yea
C. Denise Marcelle Democrat Yea
Candace N. Newell Democrat Yea
Chasity Martinez Democrat Yea
Dana Henry Democrat Yea
Delisha Boyd Democrat Yea
Ed Murray Democrat Yea
Edmond Jordan Democrat Yea
Gerald Boudreaux Democrat Yea
III, Ed Larvadain Democrat Yea
Joy Walters Democrat Yea
Jr., Kyle M. Green Democrat Not Voting
Ken Brass Democrat Yea
Mandie Landry Democrat Yea
Marcus Anthony Bryant Democrat Yea
Pat Moore Democrat Yea
Rashid Armand Young Democrat Yea
Robby Carter Democrat Not Voting
Rodney Lyons Democrat Yea
Roy Daryl Adams Democrat Yea
Shaun Raphael Mena Democrat Yea
Sr., Wilford Carter Democrat Not Voting
Steven Jackson Democrat Yea
Sylvia Elaine Taylor Democrat Yea
Tammy T. Phelps Democrat Yea
Tehmi Jahi Chassion Democrat Yea
Vanessa Caston LaFleur Democrat Yea
Annie Spell Republican Yea
Barbara Reich Freiberg Republican Yea
Beth Anne Billings Republican Yea
Brett F. Geymann Republican Yea
Brian Leonard Glorioso Republican Yea
Bryan Fontenot Republican Yea
Chad Michael Boyer Republican Yea
Chance Keith Henry Republican Yea
Christopher Turner Republican Yea
Danny McCormick Republican Not Voting
Daryl Andrew Deshotel Republican Yea
Debbie Villio Republican Yea
Dixon Wallace McMakin Republican Yea
Dodie Horton Republican Yea
Emily Chenevert Republican Yea
Foy Bryan Gadberry Republican Yea
Francis C. Thompson Republican Yea
Gregory A. Miller Republican Yea
III, Roger William Wilder Republican Yea
III, Vincent E. Cox Republican Yea
IV, Gerald "Beau" Beaullieu Republican Yea
Jack McFarland Republican Yea
Jacob Braud Republican Yea
Jacob Jules Landry Republican Yea
Jason Brian DeWitt Republican Yea
Jeffrey "Jeff" Fons Wiley Republican Yea
Jeremy LaCombe Republican Yea
Jerome Zeringue Republican Yea
Jessica Domangue Republican Yea
John E. Wyble Republican Yea
Joseph A. Orgeron Republican Yea
Josh Carlson Republican Yea
Jr., Dennis Bamburg Republican Yea
Jr., John R. Illg Republican Yea
Jr., Michael Robert Bayham Republican Yea
Kathy Edmonston Republican Not Voting
Kellee Hennessy Dickerson Republican Yea
Kim Carver Republican Yea
Kimberly Landry Coates Republican Yea
Larry A. Bagley Republican Not Voting
Lauren Ventrella Republican Yea
Laurie Schlegel Republican Yea
Les Farnum Republican Yea
Mark Wright Republican Yea
Michael "Gabe" Firment Republican Yea
Michael Charles Echols Republican Yea
Michael Melerine Republican Yea
Mike Johnson Republican Yea
Neil Riser Republican Yea
Nicholas Muscarello Republican Yea
Paul Sawyer Republican Yea
Phillip Eric Tarver Republican Yea
Polly Thomas Republican Yea
R. Dewith Carrier Republican Not Voting
Raymond J. Crews Republican Yea
Reese "Skip" Broussard Republican Yea
Rhonda Gaye Butler Republican Yea
Robert "Bob" Owen Republican Yea
Rodney Schamerhorn Republican Yea
Ryan Bourriaque Republican Yea
Shane Mack Republican Yea
Sr., Peter F. Egan Republican Yea
Stephanie H. Berault Republican Yea
Stephanie Hilferty Republican Yea
Timothy P. Kerner Republican Yea
Tony Bacala Republican Yea
Troy Jude Hebert Republican Yea
Wayne McMahen Republican Yea

Official roll call →

CO-AUTHORS (#358)

Passed 25 Yea · 0 Nay · 14 Other
Party YeaNayPresentNot Voting
Unaffiliated 1000
Democrat 10001
Republican 140013
Total 250014
% of votes cast 64%0%0%36%
How each member voted (39)
Member Party Vote
Mr. President — Yea
Edward J. Price Democrat Yea
Gary Carter Democrat Yea
Gerald Boudreaux Democrat Yea
Jay Luneau Democrat Yea
Jimmy Harris Democrat Yea
Katrina R. Jackson-Andrews Democrat Yea
Larry Selders Democrat Yea
Regina Barrow Democrat Not Voting
Royce Duplessis Democrat Yea
Sam Jenkins Democrat Yea
Sidney Barthelemy II Democrat Yea
Adam Bass Republican Yea
Alan Seabaugh Republican Yea
Beth Mizell Republican Yea
Blake Miguez Republican Yea
Bob Hensgens Republican Not Voting
Brach Jerad Myers Republican Yea
Caleb Kleinpeter Republican Yea
Eddie J. Lambert Republican Not Voting
Franklin J. Foil Republican Not Voting
Glen Womack Republican Yea
Gregory A. Miller Republican Yea
Heather Cloud Republican Not Voting
Jeremy Stine Republican Yea
John C. "Jay" Morris Republican Not Voting
Jr., William "Bill" Wheat Republican Yea
Kirk Talbot Republican Yea
Mark Abraham Republican Not Voting
Michael "Big Mike" Fesi Republican Yea
Mike Reese Republican Not Voting
Patrick Connick Republican Yea
Patrick McMath Republican Not Voting
Rick Edmonds Republican Yea
Robert "Bob" Owen Republican Not Voting
Robert Allain Republican Not Voting
Stewart Jr. Cathey Republican Not Voting
Thomas A. Pressly Republican Not Voting
Valarie Hodges Republican Not Voting

Official roll call →

FINAL PASSAGE (#357)

Passed 37 Yea · 0 Nay · 2 Other
Party YeaNayPresentNot Voting
Unaffiliated 1000
Republican 26001
Democrat 10001
Total 37002
% of votes cast 95%0%0%5%
How each member voted (39)
Member Party Vote
Mr. President — Yea
Edward J. Price Democrat Yea
Gary Carter Democrat Yea
Gerald Boudreaux Democrat Yea
Jay Luneau Democrat Yea
Jimmy Harris Democrat Yea
Katrina R. Jackson-Andrews Democrat Yea
Larry Selders Democrat Yea
Regina Barrow Democrat Not Voting
Royce Duplessis Democrat Yea
Sam Jenkins Democrat Yea
Sidney Barthelemy II Democrat Yea
Adam Bass Republican Yea
Alan Seabaugh Republican Yea
Beth Mizell Republican Yea
Blake Miguez Republican Yea
Bob Hensgens Republican Yea
Brach Jerad Myers Republican Yea
Caleb Kleinpeter Republican Yea
Eddie J. Lambert Republican Yea
Franklin J. Foil Republican Yea
Glen Womack Republican Yea
Gregory A. Miller Republican Yea
Heather Cloud Republican Yea
Jeremy Stine Republican Yea
John C. "Jay" Morris Republican Yea
Jr., William "Bill" Wheat Republican Yea
Kirk Talbot Republican Yea
Mark Abraham Republican Yea
Michael "Big Mike" Fesi Republican Yea
Mike Reese Republican Yea
Patrick Connick Republican Yea
Patrick McMath Republican Yea
Rick Edmonds Republican Yea
Robert "Bob" Owen Republican Yea
Robert Allain Republican Yea
Stewart Jr. Cathey Republican Yea
Thomas A. Pressly Republican Yea
Valarie Hodges Republican Not Voting

Official roll call →

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors SB 43?
SB 43 is sponsored by St. Blanc, John E. Wyble (Republican), Mark Wright (Republican), Joy Walters (Democrat), Lauren Ventrella (Republican), Sylvia Elaine Taylor (Democrat), Joe Stagni, Annie Spell (Republican), Rodney Schamerhorn (Republican), Paul Sawyer (Republican), Neil Riser (Republican), Ed Murray (Democrat), Pat Moore (Democrat), Dustin Miller (Democrat), Michael Melerine (Republican), Dixon Wallace McMakin (Republican), Shane Mack (Republican), Rodney Lyons (Democrat), Jacob Jules Landry (Republican), Vanessa Caston LaFleur (Democrat), Alonzo L. Knox (Democrat), Timothy P. Kerner (Republican), Mike Johnson (Republican), Steven Jackson (Democrat), Dodie Horton (Republican), Stephanie Hilferty (Republican), Chance Keith Henry (Republican), Troy Jude Hebert (Republican), Brian Leonard Glorioso (Republican), Barbara Reich Freiberg (Republican), Aimee Adatto Freeman (Democrat), Adrian Fisher (Democrat), Sr., Peter F. Egan (Republican), Michael Charles Echols (Republican), Jessica Domangue (Republican), Kellee Dickerson, Jason Brian DeWitt (Republican), Daryl Andrew Deshotel (Republican), Raymond J. Crews (Republican), III, Vincent E. Cox (Republican), Kimberly Landry Coates (Republican), Emily Chenevert (Republican), Tehmi Jahi Chassion (Democrat), Kim Carver (Republican), Barbara Carpenter (Democrat), Marcus Anthony Bryant (Democrat), Reese "Skip" Broussard, Ken Brass (Democrat), Chad Michael Boyer (Republican), Delisha Boyd (Democrat), Beth Anne Billings (Republican), Stephanie H. Berault (Republican), Jr., Michael Robert Bayham (Republican), Roy Daryl Adams (Democrat), Glen Womack (Republican), Jr., William "Bill" Wheat (Republican), Kirk Talbot (Republican), Jeremy Stine (Republican), Larry Selders (Democrat), Alan Seabaugh (Republican), Edward J. Price (Democrat), Robert "Bob" Owen (Republican), Brach Jerad Myers (Republican), Beth Mizell (Republican), Gregory A. Miller (Republican), Blake Miguez (Republican), Jay Luneau (Democrat), Caleb Kleinpeter (Republican), Sam Jenkins (Democrat), Katrina R. Jackson-Andrews (Democrat), Bob Hensgens (Republican), Cameron Henry (Republican), Jimmy Harris (Democrat), Rick Edmonds (Republican), Royce Duplessis (Democrat), Patrick Connick (Republican), Heather Cloud (Republican), Gary Carter (Democrat), Gerald Boudreaux (Democrat), Adam Bass (Republican), Sidney Barthelemy II (Democrat), Patrick McMath (Republican), and Michael "Big Mike" Fesi (Republican).
What is the current status of SB 43?
This bill has been enacted into law. Introduced February 12, 2026. Enacted.
Where can I track SB 43?
Track SB 43 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 43

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 43

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →